Viscosupplementation in symptomatic severe hip osteoarthritis: a review of the literature and report on 60 patients
- PMID: 17152419
Viscosupplementation in symptomatic severe hip osteoarthritis: a review of the literature and report on 60 patients
Abstract
Osteoarthritis of the hip is a frequent joint disorder in adults aged 50 years and older. The management focuses on pain reduction, by means of non-steroidal anti-inflammatory drugs and analgesics, physical therapy and weight reduction. When these treatments fail, total hip replacement can be considered. Viscosupplementation is a local therapeutic approach with the objective to decrease pain and to improve joint mobility. The treatment consists of injecting hyaluronic acid or hyaluronate derivatives intra-articularly. Although this approach is frequently used in young sportive adults to avoid knee surgery, its use in the severe osteoarthritic hip is less well documented. Moreover the injection of the hip joint is more difficult than injection of the knee joint, and on another hand the general condition of the patients is often already compromised. In this article we present a literature review on the subject and report the results in 60 patients who received intraarticular viscosupplementation of the hip with the objective to delay total hip replacement surgery.
Similar articles
-
Efficacy of intraarticular hyaluronic acid injection through a lateral approach under fluoroscopic control for advanced hip osteoarthritis.Agri. 2010 Oct;22(4):139-44. Agri. 2010. PMID: 21153931 Clinical Trial.
-
Viscosupplementation: a suitable option for hip osteoarthritis in young adults.Eur Rev Med Pharmacol Sci. 2009 Nov-Dec;13(6):465-72. Eur Rev Med Pharmacol Sci. 2009. PMID: 20085128 Clinical Trial.
-
Intra-articular hyaluronic acid (viscosupplementation) for hip osteoarthritis.Issues Emerg Health Technol. 2007 May;(98):1-4. Issues Emerg Health Technol. 2007. PMID: 17520755 Review.
-
Intra-articular injection of hyaluronic acid (MW 1,500-2,000 kDa; HyalOne) in symptomatic osteoarthritis of the hip: a prospective cohort study.Arch Orthop Trauma Surg. 2011 Dec;131(12):1677-85. doi: 10.1007/s00402-011-1353-y. Epub 2011 Aug 4. Arch Orthop Trauma Surg. 2011. PMID: 21814776
-
Is there evidence to support the inclusion of viscosupplementation in the treatment paradigm for patients with hip osteoarthritis?Clin Exp Rheumatol. 2005 Sep-Oct;23(5):711-6. Clin Exp Rheumatol. 2005. PMID: 16173254 Review.
Cited by
-
Significant synovial pathology in a meniscectomy model of osteoarthritis: modification by intra-articular hyaluronan therapy.Rheumatology (Oxford). 2008 Aug;47(8):1172-8. doi: 10.1093/rheumatology/ken219. Epub 2008 Jun 19. Rheumatology (Oxford). 2008. PMID: 18565987 Free PMC article.
-
[Osteoarthritis: what internists should know].Internist (Berl). 2015 May;56(5):527-41; quiz 542-3. doi: 10.1007/s00108-014-3618-3. Internist (Berl). 2015. PMID: 25903092 Review. German.
-
[Pharmacological therapy of arthrosis].Z Rheumatol. 2013 Nov;72(9):885-94; quiz 895. doi: 10.1007/s00393-013-1280-0. Z Rheumatol. 2013. PMID: 24193191 German.
-
Comparison of intra-articular injections of hyaluronic acid and corticosteroid in the treatment of osteoarthritis of the hip in comparison with intra-articular injections of bupivacaine. Design of a prospective, randomized, controlled study with blinding of the patients and outcome assessors.BMC Musculoskelet Disord. 2010 Nov 16;11:264. doi: 10.1186/1471-2474-11-264. BMC Musculoskelet Disord. 2010. PMID: 21080920 Free PMC article. Clinical Trial.
-
Use of Reticulated Hyaluronic Acid Alone or Associated With Ozone Gas in the Treatment of Osteoarthritis Due to Hip Dysplasia in Dogs.Front Vet Sci. 2020 May 13;7:265. doi: 10.3389/fvets.2020.00265. eCollection 2020. Front Vet Sci. 2020. PMID: 32478113 Free PMC article.